GM TOMATO OFFERS CHEAP SOURCE OF DRUG VS PARKINSON’S DISEASE
- By The Financial District
- Dec 19, 2020
- 2 min read
Scientists have produced a tomato enriched in the Parkinson's disease drug L-DOPA (also known as levodopa) in what could become a new, affordable source of one of the world's essential medicines, ScienceDaily reported recently.

The development of the genetically modified (GM) tomato by the John Innes Center in the United Kingdom (UK) has implications for developing nations where access to pharmaceutical drugs is restricted.
This novel use of tomato plants as a natural source of L-DOPA also offers benefits for people who suffer adverse effects -- including nausea and behavioral complications -- of chemically synthesized L-DOPA. The study was published by the journal Metabolic Engineering.
Tomato -- was chosen as a widely cultivated crop that can be used for scaled up production and potentially offering a standardized and controlled natural source of L-DOPA.
The John Innes Centre led team modified the tomato fruit by introducing a gene responsible for the synthesis of L-DOPA in beetroot where it functions in the production of the pigments betalains. L-DOPA is produced from tyrosine, an amino acid found in many foods.
The research team inserted a gene encoding a tyrosinase, an enzyme that uses tyrosine to build molecules such as L-DOPA. This elevated the level of L-DOPA specifically in the fruit part of the plant and led to higher yields than those associated with L-DOPA production in the whole plant.
The levels achieved in the tomato fruit -- 150mg of L-DOPA per kg of tomatoes -- were comparable those observed in other L-DOPA accumulating plants -- without some of the known drawbacks that have hampered plant metabolic production of the drug previously.
The aim now is to create a production pipeline where L-DOPA is extracted from the tomatoes and purified into the pharmaceutical product. Prof. Cathie Martin, corresponding author of the study explains: "The idea is that you can grow tomatoes with relatively little infrastructure.
As GMOs (genetically modified organisms) you could grow them in screen houses, controlled environments with very narrow meshes, so you would not have pollen escape through insects.
WEEKLY FEATURE